Acrylamide

Acrylamide

SCHEMBL5694435

C=CC(N)=O.CNC.CNC.Cl

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acrylamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN known ✓ Q96SW2 1/20 0.30
MAOA known ✓ P21397 1/20 0.30
MAOB known ✓ P27338 1/20 0.30
CA2 known ✓ P00918 1/20 0.30
TSHR P16473 7/20 0.69
ALDH1A1 P00352 5/20 0.69
FGFR4 P22455 1/20 0.69
LMNA P02545 4/20 0.37
TDP1 Q9NUW8 2/20 0.33
BLM P54132 2/20 0.33
PMP22 Q01453 2/20 0.33
MAPK1 P28482 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 2/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
THPO P40225 1/20 0.30
CYP3A4 P08684 1/20 0.30
CA5A P35218 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL5694442 1.00
Acrylamide SCHEMBL659888 0.97
Acrylamide SCHEMBL20561989 0.94 TSHR (0.69) TSHRALDH1A1FGFR4LMNATDP1
Acrylic Acid SCHEMBL28227634 0.92 ALDH1A1 (0.58) TSHRALDH1A1FGFR4LMNAALOX15
Acrylamide SCHEMBL20515124 0.91 ALDH1A1 (0.65) TSHRALDH1A1FGFR4LMNATDP1
Acrylic Acid SCHEMBL27675250 0.88 ALDH1A1 (0.61) TSHRALDH1A1FGFR4LMNATDP1
Acrylamide SCHEMBL28037683 0.87
Acrylamide SCHEMBL5739810 0.87
Acrylamide SCHEMBL2515155 0.87
Acrylamide SCHEMBL332483 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278505-B1 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2006-04-19 EP claimed
US-6696053-B1 FREE OF LARGE AMOUNTS OF FATTY ALCOHOL; STYLING UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-02-24 US claimed
EP-1278505-A2 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2003-01-29 EP claimed
WO-2001082879-A2 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2001-11-08 WO claimed
CN-108472930-B Three-dimensional metal insulation component 哈金森公司 2020-07-21 CN disclosed
EP-1278505-B1 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2006-04-19 EP disclosed
US-6696053-B1 FREE OF LARGE AMOUNTS OF FATTY ALCOHOL; STYLING UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-02-24 US disclosed
CN-1462184-A Hair dye composition for dressing hair COSOBEAUTY LTD (JP) 2003-12-17 CN disclosed
US-20030145395-A1 Hair dye compositions for dressing the hair COSMOBEAUTY CO., LTD. (JP) 2003-08-07 US disclosed
EP-1278505-A2 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2003-01-29 EP disclosed
WO-2001082879-A2 LEAVE-ON OR RINSE-OUT HAIR CARE CONDITIONER COMPOSITIONS CONTAINING SILICONE QUATERNARY COMPOUNDS AND THICKENERS UNILEVER PLC (GB) 2001-11-08 WO disclosed
US-3920599-A Latices of dially dimethyl ammonium chloride/acrylamide polymers NALCO CHEMICAL CO 1975-11-18 US disclosed